Blackmores Share Price Rises on New Acquisition and Record Sales

By ,

Blackmores Limited [ASX:BKL] share price increased immediately upon opening, after revealing the acquisition of Probiotec Limited’s [ASX:PBP] IMPROMY brand and its record sales and profit growth.

It’s no surprise with this strategic acquisition and record results Blackmores saw a spike in its share value. Shares in the company are currently trading at $156.91, up 8.03%.

Details of Blackmores new acquisition

IMPROMY is a consultation-based health and weight loss program, developed in collaboration with CSIRO, an Australian federal agency responsible for scientific research.

Probiotec will receive $9 million in cash upon settlement of the sale, which is expected to be November this year, subject to normal adjustments.

Probiotec’s Managing Director, Wes Stringer believes that IMPROMY is well positioned for growth under Blackmores ownership.

Free Report: Discover four red hot ASX profit plays for 2018. Read Now.

Blackmores record full-year results

The health supplement company reported record full-year profits with $601 million in revenue, up 9% from the previous year. And net profit after tax was $70 million, a 19% increase from the year before.

Blackmores Chief Executive Officer Richard Henfrey said that the company was focused on driving stability within the business to enable sustainable growth.

Our results for the year reflect this focus.

Revenue was a record for the Group and in the financial year we sold more product than ever in our 86-year history. The strongest growth continues to come from our businesses in Asia, which delivered record sales in June.

Looking forward, the company is focused on delivering growth across all of its brands, particularly investment opportunities.

Blackmores stated in its full-year results that China continues to be a significant opportunity for the company.

In addition to our Alibaba agreement, last week we signed a strategic co-operation with NetEase Kaola,

Our vision for China is not limited to e-commerce sales, and we’re actively building our offline business and affirming our credibility as a leading natural health advocate’ said Mr Henfrey.

To top off the good news, the company reported a final fully-franked dividend of 155 cents per share, up 13% from the year prior.


Matt Hibbard
For Money Morning

PS: You’ll find over 2,000 stock listed on the ASX and on any given day a bunch will rise, just like Blackmores. It’s near impossible to monitor these on your own. Our analyst Sam Volkering has picked out four Aussie stocks he believes could be top performers in 2018. Check out his free report ‘The Four Best ASX Stocks for 2018’.


About Matt Hibbard

Probiotec Shares Up As It Majorly Ups Guidance for FY21 (ASX:PBP)

Aspiring pill-packer Probiotec Ltd [ASX:PBP] share price is up 7.18% today, rising on the back of upgraded guidance from management…

Probiotec Shares Rocket Higher on Strategic Acquisition

Local outfit Probiotec Ltd [ASX:PBP] is up 18% at time of writing. Soaring on the back of new takeover talks. And, as a key drug packer and distributor, they may have a lot of work ahead of them in the near future. So this acquisition may be a very timely indeed.

Blackmores Share Price Down on Third Quarter Results

The latest news out of the company is the release of its third quarter results which reveal a 43% drop in profit. Blackmores has all the hallmarks of a ‘hold’ rating. 

Blackmores Drops 32% despite Solid Profit

Today’s first half results are reminiscent of Blackmores’ glory days of 2015 and 2016 when profits soared on the back of huge demand for high quality vitamins from Australia. Sadly, those days might be over.

Star Combo Share Price Up 23.64% after Chinese Retailer Acquisition

The share price of Australian nutritional business, Star Combo Pharma Limited [ASX:S66], has rocketed up over 23% this morning. Star Combo shares were placed in a trading halt yesterday as the company brokered a deal to acquire the e-commerce platform Austoyou Group.